-
2024 CSCO YOUNG | Dr. Biyun Wang: Focusing on Cancer Treatment and the Development of Young Oncologists
On December 28, 2024, the year-end meeting of the Youth Expert Committee of the Chinese Society of Clinical Oncology (CSCO) was successfully held in Shanghai. This event brought together renowned experts and promising young talents from across the country to explore new directions in cancer treatment. Oncology Frontier had the honor of interviewing Dr. Biyun…
-
ASH 2024 | Dr. Kai Hu: Advancing CAR-T Therapy in Relapsed/Refractory Malignant Lymphoma and Multiple Myeloma
The 66th American Society of Hematology (ASH) Annual Meeting was held from December 7–10, 2024, in San Diego, USA. As one of the world’s largest international academic conferences in the field of hematology, ASH brings together cutting-edge research and the latest drug development data, showcasing the highest level of global hematology research. During this event,…
-
2024 Beijing City Annual Lung Cancer Conference | Dr. Yong Song: Advances and Challenges in Anti-Angiogenic Therapy for Lung Cancer
As the year draws to a close, reflection and progress take center stage. The “2024 Beijing Forbidden City Annual Lung Cancer Conference and the 16th Multidisciplinary Seminar on Advances in Lung Cancer Diagnosis and Treatment,” jointly organized by the Beijing Tumor Prevention and Research Association, the China Association of Senior Healthcare, the Beijing Medical Love…
-
ASH 2024 | Dr. Zhihui Li: Prognostic Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Advanced Relapsed/Refractory NKTCL Patients
The 66th American Society of Hematology (ASH) Annual Meeting was held from December 7–10, 2024, in San Diego, USA. As one of the largest global academic events in hematology, it showcased cutting-edge research and the latest drug development data. At this prestigious conference, Dr. Zhihui Li from Beijing GoBroad Boren Hospital (Dr. Tong Wu ’s…
-
Advancing Liver Cancer Treatment | Dr. Ming Zhao, Sun Yat-sen University Cancer Center
Dr. Ming Zhao shares key insights on combining local and systemic therapies to improve liver cancer treatment outcomes. Learn how innovative approaches like immunotherapy and targeted treatments are transforming patient care.
-
ESMO Asia 2024 | Dr. Jae-Lyun Lee ： Advances in the Management of Advanced Renal Cell Carcinoma
Urology Frontier: What is the role of multidisciplinary team evaluations for patients with advanced RCC? Dr. Jae-Lyun Lee:At my institution in South Korea, we have a dedicated multidisciplinary team for…
-
Dr. Rui Xu: New Advances in Surgical Treatment of Breast Cancer and Insights into Integrative Medicine | 2024 Yixian Breast Cancer Conference
The 2024 Yixian Breast Cancer Conference and the 2nd China Young Breast Cancer Consensus Conference, held on December 27–28 in Guangzhou, brought together leading experts in breast disease to discuss the latest advancements in treatment and management. The conference also focused on consensus guidelines for diagnosing and treating young breast cancer patients, aiming to improve…
Connecting Medical Expertise through Media
